References
- Futrakul N, Vongthavarawat V, Sirisalipotch S, et al. Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. Clin Hemorheol Microcirc. 2005;32:59–65
- Futrakul N, Butthep P, Vongthavarawat V, et al. Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively. Clin Hemorheol Microcirc. 2006;34:373–381
- Ritt M, Ott C, Raff W, et al. Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am J Kidney Dis. 2009;53:281–289
- Vora JP, Dolben J, Dean JD, et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int. 1990;41:829–835
- Ishida K, Ishibashi F, Takashina S. Comparison of renal hemodynamics in early non-insulin-dependent and insulin-dependent diabetes mellitus. J Diabetes Complications. 1991;5:143–145
- Vallon V, Wead LM, Blantz RC. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes in rates: Effect of sodium and salt restriction. J Am Soc Nephrol. 1995;5:1761–1767
- Futrakul N, Futrakul P. Renal microvascular disease predicts renal function in diabetes. Ren Fail. 2012;34:126–129
- Futrakul N, Futrakul P. Indices indicating early renal microvascular disease in diabetes. Open Biomarker J. 2011;4:18–20
- Futrakul N, Kittikowit W, Yenrudi S. Reduced endothelial factor VIII staining in renal microcirculation correlates with hemodynamic alteration in nephrosis. Ren Fail. 2003;25:757–764
- Osterby R, Bangstad HJ, Nyberg G, et al. On glomerular structural altertions in type 1 diabetes: Companions of early diabetic glomerulopathy. Virchows Arch. 2001;438:129–135
- Futrakul N, Futrakul P. Diabetic nephropathy: Current concept of therapeutic strategy toward self-sufficiency. J Nephrol Ther. 2011 S2. doi:10.4172/2161-0959.1000109
- Futrakul N, Sila-Asna M, Futrakul P. Therapeutic strategy towards renal restoration in chronic kidney disease. Asian Biomed. 2007;1:33–44
- Obrador GT, Pereira BJ, Kausz AT. Chronic kidney disease in the United States: An underrecognized problem. Semin Nephrol. 2002;22:441–448
- Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39:445–449
- Pontremodi R, Leoncini G, Revara M, et al. Microalbuminuria, cardiovascular, and renal risk in primary hypertension. J Am Soc Nephrol. 2002;13(Suppl 3):S169–S172
- Futrakul N, Futrakul P. Renal microvascular and tubular injuries in type 2 diabetic nephropathy. Kidney Int. 2009;74:390. doi: 10.1038/ki.2008.173
- Kang DH, Kanellis J, Hugo C, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002;13:806–816
- Nakagawa T, Kang DH, Ohashi R, et al. Tubulointerstitial disease: Role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens. 2003;12:233–241
- Bohle A, Mackensen-Haen S, Wehrmanu M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res. 1996;19:191–195
- Yenrudi S, Laohapaibul A, Kittidivit W, et al. A correlation between renal morphology and renal circulation in pediatric nephrotic syndrome. Ren Fail. 2001;23:85–90
- Kang DH, Joly AH, Oh SW, et al. Impaired angiogenesis in the remnant kidney model: I Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol. 2001;12:1434–1447
- Futrakul N, Yenrudi S, Sensirivatana R, et al. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren Fail. 2000;22:329–335
- Futrakul N, Futrakul P. Vascular resfponse to vasodilator treatment in microalbuminuria DKD. World J Nephrol. 2013;2:125–128
- Defenasi G, Revera M, Berruti V, et al. Optimizing therapy in the diabetic patient with renal disease: Antihypertensive treatment. J Am Soc Nephrol. 2005;15:6–11
- Schmieder RE, Delles C, Mimran A, et al. Impact of telmisartan versus ramipril on renal endothelial function in patients and type 2 diabetes. Diabetes Care. 2007;30:1351–1356
- The HOPE Investigators. Effect of ramipril on cardiovascular and microvascular outcome in people with diabetes mellitus: Result of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253–259
- Lewis J. Increasing telmisartan vs amlodipine dose in patients with hypertension, type 2 diabetes and microalbuminuria. Nat Clin Pract Nephrol. 2007;8:476–477
- Ffutrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in type 2 diabetic nephropathy. Ren Fail. 2009;31:207–210
- Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 12 diabetes. Int J Vasc Med. 2011;2011:971524. doi:10.1155/2011/971524
- Futrakul N, Chaisuriya P, Ratanabanangkoon K, et al. Microvascular dysfunction in normotensive, normoalbuminuric, normo- or hyperfiltrate type 2 diabetes. Ren Fail. 2013;35:1191–1192
- Futrakul N, Kulapatana O, Futrakul P. Vascular disease in early stage of diabetic nephropathy. Ren Fail. 2013;35:1302–1303
- Futrakul N, Buttthep P, Futrakul P. Altered vascular homeostasis in chronic kidney disease. Clin Hemorheol Microcirc. 2008;38:201–207
- Futrakul P, Yenrudi S, Futrakul N, et al. Tubular function and tubulointerstial disease. Am J Kidney Dis. 1999;33:886–891
- Deekajorndech T. A biomarker for detecting early tubulointerstitial disease and ischemia in glomerulonephropathy. Ren Fail. 2007;29:1013–1017
- Futrakul N, Futrakul P. Vascular repair is adequately functional in early stage of diabetic nephropathy. Asian Biomed. 2010;4:987–990
- Futrakul N, Futrakul P. A mildly altered vascular homeostasis in early stage of CKD. Ren Fail. 2009;31:538–543
- Futrakul N, Butthep P, Futrakul P, et al. Improvement of renal function in type 2 diabetic nephropathy. Ren Fail. 2007;29:155–158
- Futrakul N, Kulapatana O, Futrakul P, et al. Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy. Ren Fail. 2011;33:312–315
- Futrakul N, Booyen M, Patumraj S, et al. Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators. Clin Hemorheol Microcirc. 2003;29:205–210
- Futrakul N, Futrakul P. Normalization of kidney dysfunction in normotensive, normoalbuminuric type 2 diabetes. Ren Fail. 2013;35:1058–1059
- Futrakul N, Futrakul P. Vascular repair is vulnerable to renal regeneration in early stage of diabetic nephropathy. Asian Biomed. 2010;4:827–828